These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17711659)

  • 21. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
    Kar S; Makkar R
    Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient.
    Höblinger A; Tiemann K; Nickenig G; Sauerbruch T; Lammert F
    Z Gastroenterol; 2008 Oct; 46(10):1194-7. PubMed ID: 18937189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and efficacy comparison of myocardial contrast enhancement-guided and angio-pressure-guided transcoronary ablation of septal hypertrophy for patients with hypertrophic obstructive cardiomyopathy].
    Gao YC; Li Y; Wu XS; Jia CQ; Jiang TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):540-3. PubMed ID: 17711715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy.
    Yue-Cheng H; Zuo-Cheng L; Xi-Ming L; Yuan DZ; Dong-Xia J; Ying-Yi Z; Hui-Ming Y; Hong-Liang C
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):86-93. PubMed ID: 23078085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular longitudinal systolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a long-term follow-up study focused on speckle tracking echocardiography.
    Sommer A; Poulsen SH; Mogensen J; Thuesen L; Egeblad H
    Eur J Echocardiogr; 2010 Dec; 11(10):883-8. PubMed ID: 20667848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial perfusion and metabolism after transcoronary ablation of septum hypertrophy (TASH) in hypertrophic obstructive cardiomyopathy.
    Lerch H; Schäfers M; Gietzen F; Schäfers K; Kuwert T; Kuhn H; Schober O
    Nuklearmedizin; 1997 Sep; 36(6):218-22. PubMed ID: 9380540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions.
    Gietzen FH; Leuner CJ; Obergassel L; Strunk-Mueller C; Kuhn H
    Circulation; 2002 Jul; 106(4):454-9. PubMed ID: 12135945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
    Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
    Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society.
    Faber L; Seggewiss H; Gietzen FH; Kuhn H; Boekstegers P; Neuhaus L; Seipel L; Horstkotte D
    Z Kardiol; 2005 Aug; 94(8):516-23. PubMed ID: 16049653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of permanent cardiac pacing in hypertrophic and obstructive cardiomyopathies resistant to medical treatment].
    Sadoul N; Simon JP; de Chillou C; Bruntz JF; Isaaz K; Beurrier D; Reeb T; Dodinot B; Aliot E
    Arch Mal Coeur Vaiss; 1994 Oct; 87(10):1315-23. PubMed ID: 7771876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
    Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
    Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Buergler JM; Quinones MA; Spencer WH; Lawrie GM
    J Am Coll Cardiol; 2007 Aug; 50(8):795-8. PubMed ID: 17707185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.
    Sohns C; Sossalla S; Schmitto JD; Jacobshagen C; Raab BW; Obenauer S; Maier LS
    Clin Res Cardiol; 2010 Jun; 99(6):359-68. PubMed ID: 20503122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study.
    Galve E; Sambola A; Saldaña G; Quispe I; Nieto E; Diaz A; Evangelista A; Candell-Riera J
    Heart; 2010 Mar; 96(5):352-6. PubMed ID: 19482844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dual-chamber pacemakers in obstructive hypertrophic cardiomyopathy: gradient variation with stress echocardiography].
    Martínez Martínez JG; Ortuño Alcaraz D; Marín Ortuño F; Luján Martínez J; Ibáñez Criado A; Quiles Llorens JA; Sogorb Garri F
    Rev Esp Cardiol; 1998 Jan; 51(1):51-5. PubMed ID: 9580168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.